EBM Stock Overview
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Eastwood Bio-Medical Canada Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.68 |
| 52 Week High | CA$1.15 |
| 52 Week Low | CA$0.28 |
| Beta | 0.28 |
| 11 Month Change | 4.62% |
| 3 Month Change | 19.30% |
| 1 Year Change | -15.00% |
| 33 Year Change | -54.67% |
| 5 Year Change | -67.62% |
| Change since IPO | 70.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EBM | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | -32.0% | -0.5% | 0.4% |
| 1Y | -15.0% | 41.9% | 21.4% |
Return vs Industry: EBM underperformed the Canadian Healthcare industry which returned 41.9% over the past year.
Return vs Market: EBM underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| EBM volatility | |
|---|---|
| EBM Average Weekly Movement | 68.4% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: EBM's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine EBM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Youngsoo Kim | www.eleotin.ca |
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company’s licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism.
Eastwood Bio-Medical Canada Inc. Fundamentals Summary
| EBM fundamental statistics | |
|---|---|
| Market cap | CA$67.51m |
| Earnings (TTM) | -CA$484.16k |
| Revenue (TTM) | CA$653.54k |
71.7x
P/S Ratio-96.8x
P/E RatioIs EBM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBM income statement (TTM) | |
|---|---|
| Revenue | CA$653.54k |
| Cost of Revenue | CA$246.50k |
| Gross Profit | CA$407.05k |
| Other Expenses | CA$891.21k |
| Earnings | -CA$484.16k |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.007 |
| Gross Margin | 62.28% |
| Net Profit Margin | -74.08% |
| Debt/Equity Ratio | -5.7% |
How did EBM perform over the long term?
See historical performance and comparison